Soligenix
SNGX
#11002
Rank
$7.29 M
Marketcap
$0.34
Share price
0.51%
Change (1 day)
-75.37%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2023 (TTM): -$2.66

According to Soligenix's latest financial reports the company's current EPS (TTM) is -$1.80. In 2022 the company made an earnings per share (EPS) of -$4.43 a decrease over its 2021 EPS that were of -$4.22.

EPS history for Soligenix from 1998 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.66-39.96%
2022-$4.434.93%
2021-$4.22-58%
2020-$10.0536.73%
2019-$7.35-33.78%
2018-$11.10-36.75%
2017-$17.5527.17%
2016-$13.80-70.23%
2015-$46.35-3.44%
2014-$48.00-45.76%
2013-$88.5059.46%
2012-$55.5060.87%
2011-$34.50-68.49%
2010-$109.50-8.75%
2009-$120.00100%
2008-$60.00-71.43%
2007-$210.00-46.15%
2006-$390.0062.5%
2005-$240.00-52.94%
2004-$510.00-22.73%
2003-$660.00-24.14%
2002-$870.00-75.63%
2001-$3,570138%
2000-$1,500-39.76%
1999-$2,490-62.61%
1998-$6,660

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68-471.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$0.76-142.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$1.90-205.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-$0.95-47.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$2.03 12.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$0.63-135.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
-$3.44 91.11%๐Ÿ‡บ๐Ÿ‡ธ USA